Broomfield, CO, January 17, 2016 --(PR.com
)-- MedAware Systems, Inc. announced today it has successfully completed its second phase of Beta testing.
The Company tabulated and analyzed results from its second phase of Beta testing from a diverse group of physicians and other healthcare professionals across the United Sates. Results exceeded the Company’s expectations with respect to reporting on overall functionality and usability.
Typical user comments were “This is an outstanding product and I am incredibly impressed with the overall functionality,” from a physician and Clinical Professor of Emergency Medicine at the University of California, San Francisco; another “It is very quick and easy to use,” from a physician in New York City; “…the program had exceptional flow and great ease of use. It was very intuitive and clean without excess,” from a DNP (Doctor of Nursing Practice) at the University of Colorado Health system; and "I think you have a powerful tool that provides critical data on best treatment options, while saving time,” from a medical student in upstate New York, among many others.
Comments and suggestions from the test group will be incorporated into the Company’s big medical data application for a final round of user testing in late February. Product launch is scheduled for April 2016.
“We are pleased to have successfully completed this second round of Beta testing,” said Michael Willis, CEO of MedAware Systems. He adds, “User feedback was overwhelmingly positive and suggestions on enhancing usability were quite thoughtful and detailed. We thank the entire group of Beta testers for their time and valuable insight and feedback in helping to make this a vital tool for medical treatment decision support.”
About MedAware Systems, Inc.
MedAware Systems helps physicians make the best possible treatment decision for their patients. This new Scientific-Data-as-a-Service (SDaaS)™ aggregates, organizes, and standardizes the vast body of human clinical trials research to provide instant, comprehensible, and indispensable data for the patient plan of care.